Reports for DOXORUBICIN HYDROCHLORIDE INJECTION

Brand name

DOXORUBICIN HYDROCHLORIDE INJECTION

Company Name
TEVA CANADA LIMITED
Drug Identification Number
02409275
Ingredients
DOXORUBICIN HYDROCHLORIDE
Ingredient Strength
2 MG
ATC Code
L01DB
ATC Descriptor
CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES
Status
MARKETED
Shortage reports
Brand name Packaging Size Status Date Created Date Updated Reports
DOXORUBICIN HYDROCHLORIDE INJECTION 100ML Resolved 2023-06-20 2023-10-19 195806
DOXORUBICIN HYDROCHLORIDE INJECTION 5ml Resolved 2023-01-12 2023-10-06 180891
DOXORUBICIN HYDROCHLORIDE INJECTION 5ML Resolved 2023-06-16 2023-07-05 195219
DOXORUBICIN HYDROCHLORIDE INJECTION 25 Resolved 2022-11-14 2023-01-12 174595
DOXORUBICIN HYDROCHLORIDE INJECTION 25ml VIAL Resolved 2022-01-20 2022-04-21 153156
DOXORUBICIN HYDROCHLORIDE INJECTION 100ml Resolved 2022-02-17 2022-03-24 155155
DOXORUBICIN HYDROCHLORIDE INJECTION 5ML Resolved 2021-04-21 2021-05-20 137890
DOXORUBICIN HYDROCHLORIDE INJECTION 25ML Resolved 2020-10-22 2020-11-12 126918
DOXORUBICIN HYDROCHLORIDE INJECTION 1 Resolved 2020-06-18 2020-06-25 118253
DOXORUBICIN HYDROCHLORIDE INJECTION 100ml Resolved 2020-01-09 2020-02-21 102893

Showing 1 to 10 of 14

Discontinuation reports
Brand name Packaging Size Status Date Created Date Updated Reports

Showing 1 to 0 of 0